RECRUITING

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Talk to us

Conditions

Plaque PsoriasisPsoriasisRashItchTeenDermatologyDermPOETYK-PsO-Peds-1

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate the efficacy, safety, and drug levels of Deucravacitinib (BMS-986165) in adolescent participants with moderate to severe plaque psoriasis

Official Title

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Adolescent Participants (12 Years to Less Than 18 Years) With Moderate to Severe Plaque Psoriasis

Quick Facts

Study Start:2025-08-26
Study Completion:2034-08-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06979453

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:12 Years to 17 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
CONTACT
8559073286
Clinical.Trials@bms.com
First line of the email MUST contain the NCT# and Site#
CONTACT

Principal Investigator

Bristol-Myers Squibb
STUDY_DIRECTOR
Bristol-Myers Squibb

Study Locations (Sites)

Local Institution - 0041
Birmingham, Alabama, 35243
United States
Local Institution - 0025
Fountain Valley, California, 92708
United States
Local Institution - 0090
Fremont, California, 94538
United States
Local Institution - 0214
Northridge, California, 91325
United States
Local Institution - 0077
Sacramento, California, 95814
United States
Local Institution - 0243
Walnut Creek, California, 94598
United States
Paradigm Clinical Research, LLC
Wheat Ridge, Colorado, 80033
United States
Local Institution - 0021
Clearwater, Florida, 33756
United States
Local Institution - 0185
Margate, Florida, 33063
United States
Local Institution - 0014
Miami Lakes, Florida, 33016
United States
Palm Harbor Dermatology PA d/b/a TrueBlue Clinical Research
Tampa, Florida, 33609
United States
Local Institution - 0244
Atlanta, Georgia, 30305
United States
Local Institution - 0003
Indianapolis, Indiana, 46250
United States
Local Institution - 0202
Metairie, Louisiana, 70001
United States
Local Institution - 0061
Rockville, Maryland, 20850
United States
Kuchnir Dermatology & Dermatologic Surgery
Milford, Massachusetts, 01757
United States
Local Institution - 0095
Detroit, Michigan, 48201
United States
Local Institution - 0233
Columbia, Missouri, 65201
United States
Local Institution - 0052
Las Vegas, Nevada, 89148
United States
Local Institution - 0166
The Bronx, New York, 10467
United States
Local Institution - 0234
Hickory, North Carolina, 28602
United States
Apex Clinical Research Center - Canton
Canton, Ohio, 44716
United States
Apex Clinical Research Center
Mayfield Heights, Ohio, 44124
United States
Local Institution - 0235
Goodlettsville, Tennessee, 37072
United States
Local Institution - 0248
Nashville, Tennessee, 37205
United States
Local Institution - 0033
San Antonio, Texas, 78218
United States
Local Institution - 0045
Norfolk, Virginia, 23502
United States
Local Institution - 0071
Mill Creek, Washington, 98012
United States

Collaborators and Investigators

Sponsor: Bristol-Myers Squibb

  • Bristol-Myers Squibb, STUDY_DIRECTOR, Bristol-Myers Squibb

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-08-26
Study Completion Date2034-08-12

Study Record Updates

Study Start Date2025-08-26
Study Completion Date2034-08-12

Terms related to this study

Keywords Provided by Researchers

  • Psoriasis
  • Rash
  • Itch
  • Teen
  • Dermatology
  • Derm
  • POETYK-PsO-Peds-1

Additional Relevant MeSH Terms

  • Plaque Psoriasis